시장보고서
상품코드
1278989

세계의 호흡기질환용 백신 시장 : 산업 분석, 동향, 시장 규모, 예측(-2030년)

Respiratory Disease Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

발행일: | 리서치사: Infinium Global Research (IGR) | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 호흡기질환용 백신 시장 규모는 2023-2030년의 예측 기간 중 CAGR로 5% 이상의 성장이 예측됩니다.

천식, 결핵, 폐렴, 폐암 등 호흡기질환의 유병률이 시장 성장을 촉진하고 있습니다. 또한 의료비 지출의 증가도 시장 성장을 지지하고 있습니다. 한편, 백신 승인에 관한 정부의 엄격한 정책이 시장 성장을 방해할 가능성이 있습니다.

세계의 호흡기질환용 백신 시장에 대해 조사했으며, 시장 개요, 거시 지표 분석, 질환 유형·백신·지역별 시장 분석, 기업 개요와 경쟁 구도 등에 관한 정보를 제공하고 있습니다.

목차

제1장 서문

제2장 주요 요약

  • 호흡기질환용 백신 시장 하이라이트
  • 호흡기질환용 백신 시장 예측
  • 호흡기질환용 백신 시장의 지역별 하이라이트

제3장 세계의 호흡기질환용 백신 시장 개요

  • 서론
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 기회
  • Porter의 산업 분석
  • IGR - 성장 매트릭스 분석
    • IGR - 성장 매트릭스 분석 : 질환 유형별
    • IGR - 성장 매트릭스 분석 : 백신별
    • IGR - 성장 매트릭스 분석 : 지역별
  • 호흡기질환용 백신 시장의 밸류체인 분석
  • 호흡기질환용 백신 시장 TAM SAM SOM 분석
    • TAM SAM SOM의 예측 분석(10억 달러), 2023년

제4장 호흡기질환용 백신 시장 거시 지표 분석

제5장 세계의 호흡기질환용 백신 시장 : 질환 유형별

  • 만성폐쇄성폐질환
  • 백일해
  • 폐렴
  • 홍역
  • 디프테리아

제6장 세계의 호흡기질환용 백신 시장 : 백신별

  • DTaP
  • PPSV23
  • MMR
  • HIB
  • RSV

제7장 세계의 호흡기질환용 백신 시장 : 지역별(2023-2030년)

  • 북미
    • 질환 유형별
    • 백신별
    • 국가별
  • 유럽
    • 질환 유형별
    • 백신별
    • 국가별
  • 아시아태평양
    • 질환 유형별
    • 백신별
    • 국가별
  • 기타 지역
    • 질환 유형별
    • 백신별
    • 서브 지역별

제8장 기업 개요와 경쟁 구도

  • 세계의 호흡기질환용 백신 시장의 경쟁 구도
  • 기업 개요
    • Sanofi
    • GSK plc
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Bavarian Nordic
    • EMERGENT
    • CSL Limited
    • Moderna, Inc.
    • Serum Institute of India Pvt. Ltd.
    • Sinovac Biotech
KSA 23.06.05

The report on the global respiratory disease vaccine market provides qualitative and quantitative analysis for the period from 2021-2030. The report predicts the global respiratory disease vaccine market to grow with a CAGR of above 5% over the forecast period from 2023-2030. The study on respiratory disease vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on respiratory disease vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global respiratory disease vaccine market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global respiratory disease vaccine market over the period of 2021-2030. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The prevalence of respiratory diseases such as asthma, tuberculosis, pneumonia, and lung cancer is driving the growth of the market.
  • Growing healthcare expenditure is also supporting the growth of the market.

2) Restraints

  • Strict policies by the government for the approval of vaccines may hamper the growth of the market.

3) Opportunities

  • The growing findings will provide a growth opportunity to expand the respiratory disease vaccine market.

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include:

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global respiratory disease vaccine market is segmented on the basis of disease type, and vaccine.

The Global Respiratory Disease Vaccine Market by Disease Type

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pertussis
  • Pneumonia
  • Measles
  • Diphtheria

The Global Respiratory Disease Vaccine Market by Vaccine

  • DTaP
  • PPSV23
  • MMR
  • Haemophilus Influenzae Type B (HIB)
  • Respiratory Syncytial Virus (RSV)

Company Profiles

The companies covered in the report include:

  • Sanofi
  • GSK plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bavarian Nordic
  • EMERGENT
  • CSL Limited
  • Moderna, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech

What does this Report Deliver?

  • 1. Comprehensive analysis of the global as well as regional markets of the respiratory disease vaccine market.
  • 2. Complete coverage of all the segments in the respiratory disease vaccine market to analyze the trends, developments in the global market and forecast of market size up to 2030.
  • 3. Comprehensive analysis of the companies operating in the global respiratory disease vaccine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
  • 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

Chapter 2. Executive Summary

  • 2.1. Respiratory Disease Vaccine Market Highlights
  • 2.2. Respiratory Disease Vaccine Market Projection
  • 2.3. Respiratory Disease Vaccine Market Regional Highlights

Chapter 3. Global Respiratory Disease Vaccine Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Porter`s Five Forces Analysis
  • 3.4. IGR-Growth Matrix Analysis
    • 3.4.1. IGR-Growth Matrix Analysis by Disease Type
    • 3.4.2. IGR-Growth Matrix Analysis by Vaccine
    • 3.4.3. IGR-Growth Matrix Analysis by Region
  • 3.5. Value Chain Analysis of Respiratory Disease Vaccine Market
  • 3.6. TAM SAM SOM Analysis for Respiratory Disease Vaccine Market
    • 3.6.1. TAM SAM SOM Forecast Analysis (USD Billion) 2023

Chapter 4. Respiratory Disease Vaccine Market Macro Indicator Analysis

Chapter 5. Global Respiratory Disease Vaccine Market by Disease Type

  • 5.1. Chronic Obstructive Pulmonary Disease (COPD)
  • 5.2. Pertussis
  • 5.3. Pneumonia
  • 5.4. Measles
  • 5.5. Diphtheria

Chapter 6. Global Respiratory Disease Vaccine Market by Vaccine

  • 6.1. DTaP
  • 6.2. PPSV23
  • 6.3. MMR
  • 6.4. Haemophilus Influenzae Type B (HIB)
  • 6.5. Respiratory Syncytial Virus (RSV)

Chapter 7. Global Respiratory Disease Vaccine Market by Region 2023-2030

  • 7.1. North America
    • 7.1.1. North America Respiratory Disease Vaccine Market by Disease Type
    • 7.1.2. North America Respiratory Disease Vaccine Market by Vaccine
    • 7.1.3. North America Respiratory Disease Vaccine Market by Country
      • 7.1.3.1. The U.S. Respiratory Disease Vaccine Market
        • 7.1.3.1.1. The U.S. Respiratory Disease Vaccine Market by Disease Type
        • 7.1.3.1.2. The U.S. Respiratory Disease Vaccine Market by Vaccine
      • 7.1.3.2. Canada Respiratory Disease Vaccine Market
        • 7.1.3.2.1. Canada Respiratory Disease Vaccine Market by Disease Type
        • 7.1.3.2.2. Canada Respiratory Disease Vaccine Market by Vaccine
      • 7.1.3.3. Mexico Respiratory Disease Vaccine Market
        • 7.1.3.3.1. Mexico Respiratory Disease Vaccine Market by Disease Type
        • 7.1.3.3.2. Mexico Respiratory Disease Vaccine Market by Vaccine
  • 7.2. Europe
    • 7.2.1. Europe Respiratory Disease Vaccine Market by Disease Type
    • 7.2.2. Europe Respiratory Disease Vaccine Market by Vaccine
    • 7.2.3. Europe Respiratory Disease Vaccine Market by Country
      • 7.2.3.1. Germany Respiratory Disease Vaccine Market
        • 7.2.3.1.1. Germany Respiratory Disease Vaccine Market by Disease Type
        • 7.2.3.1.2. Germany Respiratory Disease Vaccine Market by Vaccine
      • 7.2.3.2. United Kingdom Respiratory Disease Vaccine Market
        • 7.2.3.2.1. United Kingdom Respiratory Disease Vaccine Market by Disease Type
        • 7.2.3.2.2. United Kingdom Respiratory Disease Vaccine Market by Vaccine
      • 7.2.3.3. France Respiratory Disease Vaccine Market
        • 7.2.3.3.1. France Respiratory Disease Vaccine Market by Disease Type
        • 7.2.3.3.2. France Respiratory Disease Vaccine Market by Vaccine
      • 7.2.3.4. Italy Respiratory Disease Vaccine Market
        • 7.2.3.4.1. Italy Respiratory Disease Vaccine Market by Disease Type
        • 7.2.3.4.2. Italy Respiratory Disease Vaccine Market by Vaccine
      • 7.2.3.5. Spain Respiratory Disease Vaccine Market
        • 7.2.3.5.1. Spain Respiratory Disease Vaccine Market by Disease Type
        • 7.2.3.5.2. Spain Respiratory Disease Vaccine Market by Vaccine
      • 7.2.3.6. Rest of Europe Respiratory Disease Vaccine Market
        • 7.2.3.6.1. Rest of Europe Respiratory Disease Vaccine Market by Disease Type
        • 7.2.3.6.2. Rest of Europe Respiratory Disease Vaccine Market by Vaccine
  • 7.3. Asia Pacific
    • 7.3.1. Asia Pacific Respiratory Disease Vaccine Market by Disease Type
    • 7.3.2. Asia Pacific Respiratory Disease Vaccine Market by Vaccine
    • 7.3.3. Asia Pacific Respiratory Disease Vaccine Market by Country
      • 7.3.3.1. China Respiratory Disease Vaccine Market
        • 7.3.3.1.1. China Respiratory Disease Vaccine Market by Disease Type
        • 7.3.3.1.2. China Respiratory Disease Vaccine Market by Vaccine
      • 7.3.3.2. Japan Respiratory Disease Vaccine Market
        • 7.3.3.2.1. Japan Respiratory Disease Vaccine Market by Disease Type
        • 7.3.3.2.2. Japan Respiratory Disease Vaccine Market by Vaccine
      • 7.3.3.3. India Respiratory Disease Vaccine Market
        • 7.3.3.3.1. India Respiratory Disease Vaccine Market by Disease Type
        • 7.3.3.3.2. India Respiratory Disease Vaccine Market by Vaccine
      • 7.3.3.4. South Korea Respiratory Disease Vaccine Market
        • 7.3.3.4.1. South Korea Respiratory Disease Vaccine Market by Disease Type
        • 7.3.3.4.2. South Korea Respiratory Disease Vaccine Market by Vaccine
      • 7.3.3.5. Australia Respiratory Disease Vaccine Market
        • 7.3.3.5.1. Australia Respiratory Disease Vaccine Market by Disease Type
        • 7.3.3.5.2. Australia Respiratory Disease Vaccine Market by Vaccine
      • 7.3.3.6. Rest of Asia-Pacific Respiratory Disease Vaccine Market
        • 7.3.3.6.1. Rest of Asia-Pacific Respiratory Disease Vaccine Market by Disease Type
        • 7.3.3.6.2. Rest of Asia-Pacific Respiratory Disease Vaccine Market by Vaccine
  • 7.4. RoW
    • 7.4.1. RoW Respiratory Disease Vaccine Market by Disease Type
    • 7.4.2. RoW Respiratory Disease Vaccine Market by Vaccine
    • 7.4.3. RoW Respiratory Disease Vaccine Market by Sub-region
      • 7.4.3.1. Latin America Respiratory Disease Vaccine Market
        • 7.4.3.1.1. Latin America Respiratory Disease Vaccine Market by Disease Type
        • 7.4.3.1.2. Latin America Respiratory Disease Vaccine Market by Vaccine
      • 7.4.3.2. Middle East Respiratory Disease Vaccine Market
        • 7.4.3.2.1. Middle East Respiratory Disease Vaccine Market by Disease Type
        • 7.4.3.2.2. Middle East Respiratory Disease Vaccine Market by Vaccine
      • 7.4.3.3. Africa Respiratory Disease Vaccine Market
        • 7.4.3.3.1. Africa Respiratory Disease Vaccine Market by Disease Type
        • 7.4.3.3.2. Africa Respiratory Disease Vaccine Market by Vaccine

Chapter 8. Company Profiles and Competitive Landscape

  • 8.1. Competitive Landscape in the Global Respiratory Disease Vaccine Market
  • 8.2. Companies Profiles
    • 8.2.1. Sanofi
    • 8.2.2. GSK plc
    • 8.2.3. Merck & Co., Inc.
    • 8.2.4. Pfizer Inc.
    • 8.2.5. Bavarian Nordic
    • 8.2.6. EMERGENT
    • 8.2.7. CSL Limited
    • 8.2.8. Moderna, Inc.
    • 8.2.9. Serum Institute of India Pvt. Ltd.
    • 8.2.10. Sinovac Biotech
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제